Oral probiotics potential for the management of dermatological diseases is vast. However, results of available studies in skin diseases, such as atopic dermatitis (AD), are inconsistent, partly because probiotic effects are strain specific. Careful selection of probiotic strains is therefore indispensable to ensure efficacy of treatment. In this study, Lactobacillus salivarius LA307, Lactobacillus rhamnosus LA305 and Bifidobacterium bifidum PI22, three strains that were previously identified for their interesting immunomodulatory properties in allergy and/or colitis models, were assessed in the prevention of chronic skin inflammation induced by repeated applications of 12-O-tetradecanoylphorbol-13-acetate in hairless SKH-1 mice. Macroscopic and microscopic evaluation of skin lesions was performed together with measurements of serum levels of interleukin (IL)-1β, IL-6, tumour necrosis factor alpha (TNF-α), IL-17, IL-22, IL-10 and IL-4. Daily oral treatment with the three strains at the dose of 1×109 cfu/day for 3 weeks limited the development of chronic skin inflammation, the effects being strain dependent. Indeed the two Lactobacillus strains significantly limited the intensity of skin inflammation both at the macroscopic and microscopic levels. Macroscopic observations were correlated to the histological observations and the resulting microscopic score. This limitation of the development of AD-like skin lesions involved the modulation of cytokine production. Treatment with the two Lactobacillus strains induced a decrease in the serum levels of pro-inflammatory cytokines IL-1β, IL-6, TNF-α, IL-17, IL-22 and at the opposite an increase in the production of the anti-inflammatory cytokine IL-10 and also of IL-4. Globally, B. bifidum PI22 had lower benefits. These results obtained in mice suggest that L. salivarius LA307 and L. rhamnosus LA305 could be good candidates for preserving skin integrity and homeostasis via the modulation of the gut microbiota and that their use could be beneficial in dermatological conditions such as AD.
Agrawal, R., Wisniewski, J.A. and Woodfolk, J.A., 2011. The role of regulatory T cells in atopic dermatitis. Current Problems in Dermatology 41: 112-124.
'The role of regulatory T cells in atopic dermatitis ' () 41 Current Problems in Dermatology : 112 -124.
Alard, J., Peucelle, V., Boutillier, D., Breton, J., Kuylle, S., Pot, B., Holowacz, S. and Grangette, C., in press. New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches. Beneficial Microbes, in press. http://doi.org/10.3920/BM2017-0097.
Allen, J.E. and Wynn, T.A., 2011. Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathogens 7: e1002003.
'Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens ' () 7 PLoS Pathogens : e1002003.
Allen, S.J., Jordan, S., Storey, M., Thornton, C.A., Gravenor, M.B., Garaiova, I., Plummer, S.F., Wang, D. and Morgan, G., 2014. Probiotics in the prevention of eczema: a randomised controlled trial. Archives of Disease in Childhood 99: 1014-1019.
'Probiotics in the prevention of eczema: a randomised controlled trial ' () 99 Archives of Disease in Childhood : 1014 -1019.
Auriemma, M., Vianale, G., Amerio, P. and Reale, M., 2013. Cytokines and T cells in atopic dermatitis. European Cytokine Network 24: 37-44.
'Cytokines and T cells in atopic dermatitis ' () 24 European Cytokine Network : 37 -44.
Bisson, J.F., Hidalgo-Lucas, S., Bouschbacher, M. and Thomassin, L., 2013. Effects of TLC-Ag dressings on skin inflammation. Journal of Dermatology 40: 463-470.
'Effects of TLC-Ag dressings on skin inflammation ' () 40 Journal of Dermatology : 463 -470.
Bober, L.A., Rojas-Triana, A., Jackson, J.V., Leach, M.W., Manfra, D., Narula, S.K., Grace, M.J., 2000. Regulatory effects of interleukin-4 and interleukin-10 on human neutrophil function ex vivo and on neutrophil influx in a rat model of arthritis. Arthritis and Rheumatism 43: 2660-2667.
'Regulatory effects of interleukin-4 and interleukin-10 on human neutrophil function ex vivo and on neutrophil influx in a rat model of arthritis ' () 43 Arthritis and Rheumatism : 2660 -2667.
Brain, S., 2006. UK legislation of in vivo aspects in inflammation research. In: Stevenson, C.S., Marshall, L.A. and Morgan, D.W. (eds.) In vivo models of inflammation. Birkhaüser Verlag, Basel, Switzerland, pp. 177-186.
'UK legislation of in vivo aspects in inflammation research ', () 177 -186.
Cuello-Garcia, C.A., Brożek, J.L., Fiocchi, A., Pawankar, R., Yepes-Nuñez, J.J., Terracciano, L., Gandhi, S., Agarwal, A., Zhang, Y. and Schünemann, H.J., 2015. Probiotics for the prevention of allergy: a systematic review and meta-analysis of randomized controlled trials. Journal of Allergy and Clinical Immunology 136: 952-961.
'Probiotics for the prevention of allergy: a systematic review and meta-analysis of randomized controlled trials ' () 136 Journal of Allergy and Clinical Immunology : 952 -961.
d’Alessio, P.A., Mirshahi, M., Bisson, J.F. and Bene, M.C., 2014. Skin repair properties of d-Limonene and perillyl alcohol in murine models. Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry 13: 29-35.
'Skin repair properties of d-Limonene and perillyl alcohol in murine models ' () 13 Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry : 29 -35.
Drago, L., Iemoli, E., Rodighiero, V., Nicola, L., De Vecchi, E. and Piconi, S., 2011. Effects of Lactobacillus salivarius LS01 (DSM 22775) treatment on adult atopic dermatitis: a randomized placebo-controlled study. International Journal of Immunopathology and Pharmacology 24: 1037-1048.
'Effects of Lactobacillus salivarius LS01 (DSM 22775) treatment on adult atopic dermatitis: a randomized placebo-controlled study ' () 24 International Journal of Immunopathology and Pharmacology : 1037 -1048.
European Commission (EC), 2010. Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the approximation of laws, regulations, and administrative provisions of the Member States regarding the protection of animals used for scientific purposes. Official Journal of the European Union L 276: 33-79.
'Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the approximation of laws, regulations, and administrative provisions of the Member States regarding the protection of animals used for scientific purposes ' () 276 Official Journal of the European Union L : 33 -79.
Foligne, B., Nutten, S., Grangette, C., Dennin, V., Goudercourt, D., Poiret, S., Dewulf, J., Brassart, D., Mercenier, A. and Pot, B., 2007. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World Journal of Gastroenterology 13: 236-243.
'Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria ' () 13 World Journal of Gastroenterology : 236 -243.
Fölster-Holst, R., Müller, F., Schnopp, N., Abeck, D., Kreiselmaier, I., Lenz, T., Von Rüden, U., Schrezenmeir, J., Christophers, E. and Weichenthal, M., 2006. Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. British Journal of Dermatology 155: 1256-1261.
'Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis ' () 155 British Journal of Dermatology : 1256 -1261.
Foolad, N. and Armstrong, A.W., 2014. Prebiotics and probiotics: the prevention and reduction in severity of atopic dermatitis in children. Beneficial Microbes 5: 151-160.
'Prebiotics and probiotics: the prevention and reduction in severity of atopic dermatitis in children ' () 5 Beneficial Microbes : 151 -160.
Friedrich, A.D., Paz, M.L., Leoni, J., González Maglio, D.H., 2017. Message in a bottle: dialog between intestine and skin modulated by probiotics. International Journal of Molecular Sciences 18: E1067.
'Message in a bottle: dialog between intestine and skin modulated by probiotics ' () 18 International Journal of Molecular Sciences : E1067.
Fuchs-Tarlovsky, V., Marquez-Barba, M.F. and Sriram, K., 2016. Probiotics in dermatologic practice. Nutrition 32: 289-295.
'Probiotics in dermatologic practice ' () 32 Nutrition : 289 -295.
Ghoreschi, K., Thomas, P., Breit S., Dugas, M., Mailhammer, R., Van Eden, W., Van der Zee, R., Biedermann, T., Prinz, J., Mack, M., Mrowietz, U., Christophers, E., Schlöndorff, D., Plewig, G., Sander, C.A. and Röcken, M., 2003. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nature Medicine 9: 40-46.
'Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease ' () 9 Nature Medicine : 40 -46.
Guenin-Macé, L., Baron, L., Chany, A.C., Tresse, C., Saint-Auret, S., Jönsson, F., Le Chevalier, F., Bruhns, P., Bismuth, G., Hidalgo-Lucas, S., Bisson, J.F., Blanchard, N., Demangel, C., 2015. Shaping mycolactone for therapeutic use against inflammatory disorders. Science Translational Medicine 7: 289ra85.
'Shaping mycolactone for therapeutic use against inflammatory disorders ' () 7 Science Translational Medicine : 289ra85.
Hidalgo-Lucas, S., Rozan, P., Guerin-Deremaux, L., Violle, N., Baert, B., Saniez-Degrave, M.H. and Bisson J.F., 2015. Oral and topical administration of ROQUETTE Schizochytrium sp. alleviate skin inflammation and improve wound healing in mice. Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry 13: 154-164.
'Oral and topical administration of ROQUETTE Schizochytrium sp ' () 13 Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry : 154 -164.
Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P. and Isolauri, E., 2001. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357: 1076-1079.
'Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial ' () 357 Lancet : 1076 -1079.
Kim, M.S., Kim, J.E., Yoon, Y.S., Seo, J.G., Chung, M.J. and Yum, D.Y., 2016. A probiotic preparation alleviates atopic dermatitis-like skin lesions in murine models. Toxicological Research 32: 149-158.
'A probiotic preparation alleviates atopic dermatitis-like skin lesions in murine models ' () 32 Toxicological Research : 149 -158.
Knipper, J.A., Willenborg, S., Brinckmann, J., Bloch, W., Maaβ, T., Wagener, R., Krieg, T., Sutherland, T., Munitz, A., Rothenberg, M.E., Niehoff, A., Richardson, R., Hammerschmidt, M., Allen, J.E. and Eming, S.A., 2015. Interleukin-4 receptor α signaling in myeloid cells controls collagen fibril assembly in skin repair. Immunity 43: 803-816.
'Interleukin-4 receptor α signaling in myeloid cells controls collagen fibril assembly in skin repair ' () 43 Immunity : 803 -816.
Kwon, H.K., Lee, C.G., So, J.S., Chae, C.S., Hwang, J.S., Sahoo, A., Nam, J.H., Rhee, J.H., Hwang, K.C. and Im, S.H., 2010. Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proceedings of the National Academy of Sciences of the USA 107: 2159-2164.
'Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders ' () 107 Proceedings of the National Academy of Sciences of the USA : 2159 -2164.
Lee, J., Seto, D. and Bielory, L., 2008. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. Journal of Allergy and Clinical Immunology 121: 116-121.
'Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis ' () 121 Journal of Allergy and Clinical Immunology : 116 -121.
Lim, S.K., Kwon, M.S., Lee, J., Oh, Y.J., Jang, J.Y., Lee, J.H., Park, H.W., Nam, Y.D., Seo, M.J., Roh, S.W. and Choi, H.J., 2017. Weissella cibaria WIKIM28 ameliorates atopic dermatitis-like skin lesions by inducing tolerogenic dendritic cells and regulatory T cells in BALB/c mice. Scientific Reports 7: 40040.
'Weissella cibaria WIKIM28 ameliorates atopic dermatitis-like skin lesions by inducing tolerogenic dendritic cells and regulatory T cells in BALB/c mice ' () 7 Scientific Reports : 40040.
Ma, L., Xue, H.B., Guan, X.H., Shu, C.M., Wang, F., Zhang, J.H. and An, R.Z., 2014. The imbalance of Th17 cells and CD4(+) CD25(high) Foxp3(+) Treg cells in patients with atopic dermatitis. Journal of the European Academy of Dermatology Venereology 28: 1079-1086.
'The imbalance of Th17 cells and CD4(+) CD25(high) Foxp3(+) Treg cells in patients with atopic dermatitis ' () 28 Journal of the European Academy of Dermatology Venereology : 1079 -1086.
Medeiros, R., Otuki, M.F., Avellar, M.C. and Calixto, J.B., 2007. Mechanisms underlying the inhibitory actions of the pentacyclic triterpene alpha-amyrin in the mouse skin inflammation induced by phorbol ester 12-O-tetradecanoylphorbol-13-acetate. European Journal of Pharmacology 559: 227-235.
'Mechanisms underlying the inhibitory actions of the pentacyclic triterpene alpha-amyrin in the mouse skin inflammation induced by phorbol ester 12-O-tetradecanoylphorbol-13-acetate ' () 559 European Journal of Pharmacology : 227 -235.
Meneghin, F., Fabiano, V., Mameli, C. and Zuccotti, G.V., 2012. Probiotics and atopic dermatitis in children. Pharmaceuticals 5: 727-744.
'Probiotics and atopic dermatitis in children ' () 5 Pharmaceuticals : 727 -744.
Miossec, P., Chomarat, P., Dechanet, J., Moreau, J.F., Roux, J.P., Delmas, P. and Banchereau, J., 1994. Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. Arthritis and Rheumatism 37: 1715-1722.
'Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis ' () 37 Arthritis and Rheumatism : 1715 -1722.
Moreno, A.S., McPhee, R., Arruda, L.K. and Howell, M.D., 2016. Targeting the T helper 2 inflammatory axis in atopic dermatitis. International Archives of Allergy and Immunology 171: 71-80.
'Targeting the T helper 2 inflammatory axis in atopic dermatitis ' () 171 International Archives of Allergy and Immunology : 71 -80.
National Research Council (USA), 2011. Guide for the care and use of laboratory animals, 8th edition. National Academies Press, Washington, DC, USA.
'Guide for the care and use of laboratory animals, 8th edition', ().
Neau, E., Delannoy, J., Marion, C., Cottart, C.H., Labellie, C., Holowacz, S., Butel, M.J., Kapel, N. and Waligora-Dupriet, A.J., 2016. Three novel candidate probiotic strains with prophylactic properties in a murine model of cow’s milk allergy. Applied and Environmental Microbiology 82: 1722-1733.
'Three novel candidate probiotic strains with prophylactic properties in a murine model of cow’s milk allergy ' () 82 Applied and Environmental Microbiology : 1722 -1733.
Panduru, M., Panduru, N.M., Sălăvăstru, C.M. and Tiplica, G.S., 2015. Probiotics and primary prevention of atopic dermatitis: a meta-analysis of randomized controlled studies. Journal of the European Academy of Dermatology and Venereology 29: 232-242.
'Probiotics and primary prevention of atopic dermatitis: a meta-analysis of randomized controlled studies ' () 29 Journal of the European Academy of Dermatology and Venereology : 232 -242.
Peldan, P., Kukkonen, A.K., Savilahti, E. and Kuitunen, M., 2017. Perinatal probiotics decreased eczema up to 10 years of age but at 5-10 years allergic rhino-conjunctivitis was increased. Clinical and Experimental Allergy 47:975-979.
'Perinatal probiotics decreased eczema up to 10 years of age but at 5-10 years allergic rhino-conjunctivitis was increased ' () 47 Clinical and Experimental Allergy : 975 -979.
Rather, I.A., Bajpai, V.K., Kumar, S., Lim J., Paek, W.K. and Park, Y.H., 2016. Probiotics and atopic dermatitis: an overview. Frontiers in Microbiology 12: 507.
'Probiotics and atopic dermatitis: an overview ' () 12 Frontiers in Microbiology : 507.
Salmon-Her, V., Ramont, L., Godeau, G., Birembaut, P., Guenounou, M., Bernard, P. and Maquart, F.X., 2000. Implication of interleukin-4 in wound healing. Laboratory Investigation 80: 1337-1343.
'Implication of interleukin-4 in wound healing ' () 80 Laboratory Investigation : 1337 -1343.
Serezani, A.P., Bozdogan, G., Sehra, S., Walsh, D., Krishnamurthy, P., Sierra Potchanant, E.A., Nalepa, G., Goenka, S., Turner, M.J., Spandau, D.F. and Kaplan, M.H., 2017. IL-4 impairs wound healing potential in the skin by repressing fibronectin expression. Journal of Allergy and Clinical Immunology 139: 142-151.
'IL-4 impairs wound healing potential in the skin by repressing fibronectin expression ' () 139 Journal of Allergy and Clinical Immunology : 142 -151.
Shin, J.H., Chung, M.J. and Seo, J.G., 2016. A multistrain probiotic formulation attenuates skin symptoms of atopic dermatitis in a mouse model through the generation of CD4(+)Foxp3(+) T cells. Food and Nutrition Research 31: 32550.
'A multistrain probiotic formulation attenuates skin symptoms of atopic dermatitis in a mouse model through the generation of CD4(+)Foxp3(+) T cells ' () 31 Food and Nutrition Research : 32550.
Won, T.J., Kim, B., Lim, Y.T., Song, D.S., Park, S.Y., Park, E.S., Lee, D.I. and Hwang, K.W., 2011. Oral administration of Lactobacillus strains from Kimchi inhibits atopic dermatitis in NC / Nga mice. Journal of Applied Microbiology 110: 1195-1202.
'Oral administration of Lactobacillus strains from Kimchi inhibits atopic dermatitis in NC / Nga mice ' () 110 Journal of Applied Microbiology : 1195 -1202.
All Time | Past 365 days | Past 30 Days | |
---|---|---|---|
Abstract Views | 0 | 0 | 0 |
Full Text Views | 293 | 212 | 33 |
PDF Views & Downloads | 393 | 320 | 61 |
Oral probiotics potential for the management of dermatological diseases is vast. However, results of available studies in skin diseases, such as atopic dermatitis (AD), are inconsistent, partly because probiotic effects are strain specific. Careful selection of probiotic strains is therefore indispensable to ensure efficacy of treatment. In this study, Lactobacillus salivarius LA307, Lactobacillus rhamnosus LA305 and Bifidobacterium bifidum PI22, three strains that were previously identified for their interesting immunomodulatory properties in allergy and/or colitis models, were assessed in the prevention of chronic skin inflammation induced by repeated applications of 12-O-tetradecanoylphorbol-13-acetate in hairless SKH-1 mice. Macroscopic and microscopic evaluation of skin lesions was performed together with measurements of serum levels of interleukin (IL)-1β, IL-6, tumour necrosis factor alpha (TNF-α), IL-17, IL-22, IL-10 and IL-4. Daily oral treatment with the three strains at the dose of 1×109 cfu/day for 3 weeks limited the development of chronic skin inflammation, the effects being strain dependent. Indeed the two Lactobacillus strains significantly limited the intensity of skin inflammation both at the macroscopic and microscopic levels. Macroscopic observations were correlated to the histological observations and the resulting microscopic score. This limitation of the development of AD-like skin lesions involved the modulation of cytokine production. Treatment with the two Lactobacillus strains induced a decrease in the serum levels of pro-inflammatory cytokines IL-1β, IL-6, TNF-α, IL-17, IL-22 and at the opposite an increase in the production of the anti-inflammatory cytokine IL-10 and also of IL-4. Globally, B. bifidum PI22 had lower benefits. These results obtained in mice suggest that L. salivarius LA307 and L. rhamnosus LA305 could be good candidates for preserving skin integrity and homeostasis via the modulation of the gut microbiota and that their use could be beneficial in dermatological conditions such as AD.
All Time | Past 365 days | Past 30 Days | |
---|---|---|---|
Abstract Views | 0 | 0 | 0 |
Full Text Views | 293 | 212 | 33 |
PDF Views & Downloads | 393 | 320 | 61 |